Results for the substance canagliflozin

Canagliflozin is a medication used for the treatment of type 2 diabetes. It belongs to the class of SGLT2 inhibitors (sodium-glucose co-transporter 2) and works by reducing glucose reabsorption in the kidneys, leading to the elimination of excess glucose through urine.

Canagliflozin helps lower blood sugar levels and may also contribute to weight loss and reduced blood pressure. It is often used in combination with other antidiabetic medications or lifestyle changes, such as diet and exercise.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to monitor blood sugar levels during treatment to avoid hypoglycemia.

Side effects may include urinary tract infections, excessive thirst, frequent urination, or, in rare cases, diabetic ketoacidosis. Patients should inform their doctor of any adverse reactions.